1. Home
  2. TPST vs CPHI Comparison

TPST vs CPHI Comparison

Compare TPST & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TPST

Tempest Therapeutics Inc.

HOLD

Current Price

$2.36

Market Cap

30.9M

Sector

Health Care

ML Signal

HOLD

Logo China Pharma Holdings Inc.

CPHI

China Pharma Holdings Inc.

HOLD

Current Price

$0.65

Market Cap

26.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TPST
CPHI
Founded
2011
N/A
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.9M
26.3M
IPO Year
2012
2008

Fundamental Metrics

Financial Performance
Metric
TPST
CPHI
Price
$2.36
$0.65
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$11.00
N/A
AVG Volume (30 Days)
267.3K
8.8K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$295,000.00
$4,144,268.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.50
$0.50
52 Week High
$12.22
$2.60

Technical Indicators

Market Signals
Indicator
TPST
CPHI
Relative Strength Index (RSI) 63.14 52.98
Support Level $2.14 $0.53
Resistance Level $2.49 $0.66
Average True Range (ATR) 0.19 0.05
MACD 0.10 0.01
Stochastic Oscillator 88.54 87.31

Price Performance

Historical Comparison
TPST
CPHI

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

Share on Social Networks: